India, emerging markets take center stage in Dr Reddy's future growth plan - (Business Standard via NewsPoints Desk)

  • Business Standard reported Sunday that Dr. Reddy's Laboratories will keep focusing on emerging markets, including Russia and CIS countries, and India for future business growth.

  • At present, the company's combined revenues from emerging markets and India balance that of North America, where a warning letter from the FDA in 2015 hit growth.

  • CEO Erez Israel said "we will not be dependent on any single product to grow including [US]. With the notion of the past, the company focused on a relatively small number of assets…for the growth of the company."

  • Under a new strategy, the executive noted that Dr. Reddy's is focused on "multiple spaces which have synergy among them, much more opportunity less risk. So we moved from high risk, high reward to low risk, very high-reward."

  • Meanwhile, with regards growth through acquisitions, Israel remarked "we are always looking for opportunities, and we are very active on this front. The priority is on emerging markets and India in particular because this is where the area of (our) focus."

To read more NewsPoints articles, click here.